Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U01- Clinical Trial Optional)
ID: 354362Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Private Institutions of Higher Education

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for a limited competition grant titled "NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U01- Clinical Trial Optional)". This initiative aims to support research on improving cancer outcomes in American Indian and Alaska Native populations. The funding opportunity will be open to National Cancer Institute (NCI)-designated Cancer Centers with existing community outreach and collaborations with these populations. The expected publication date for the funding opportunity is Summer 2024, with an application due date in Summer 2024. The funding will be provided through cooperative agreements, and there is no cost sharing or matching requirement. The estimated total program funding is $6,000,000. Private Institutions of Higher Education are eligible to apply. The anticipated award date is September 2024, and the project is expected to start on September 30, 2024.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Intervention Research to Improve Native American Health," aimed at supporting research initiatives that enhance health outcomes for Native American populations. This initiative encourages the development of culturally appropriate health promotion, disease prevention, and treatment interventions, particularly through planning grants (R34) that may precede clinical trials. The focus is on addressing significant health disparities, including chronic diseases and substance use disorders, by fostering collaborations with Native American communities to ensure the effectiveness and cultural relevance of the interventions. Applicants can request up to $450,000 over three years, with a submission deadline of January 7, 2027. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-285.html.
    Intervention Research to Improve Native American Health (R21 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Intervention Research to Improve Native American Health (R21 Clinical Trials Optional)" aimed at supporting exploratory research to enhance health outcomes in Native American communities. This initiative seeks to fund studies that develop culturally appropriate health strategies, address health disparities, and involve community engagement, particularly emphasizing the importance of Indigenous Knowledge and collaboration with Native American researchers. Grants of up to $275,000 are available for projects lasting up to two years, with applications accepted until January 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-299.html.
    Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity through the Native American Research Centers for Health (NARCH) program, aimed at supporting federally-recognized American Indian/Alaska Native (AI/AN) tribes and organizations in health-related research. The program seeks to address health disparities within AI/AN communities by enhancing research capacity, career development, and infrastructure, allowing for various project components such as Administrative Cores, Research Projects, and Career Enhancement Projects. Successful applicants must demonstrate a commitment to culturally appropriate research, with a requirement that over 60% of requested funds be allocated to AI/AN entities, and the application process includes specific submission protocols and evaluation criteria. Interested parties can find more information and apply before the closing date of August 7, 2026, by visiting the funding opportunity announcement at NIH Grants or contacting NIH Grants Information at grantsinfo@nih.gov.
    Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Native American Research Centers for Health (NARCH) Planning Grants program, aimed at supporting federally recognized American Indian/Alaska Native (AI/AN) Tribes, Tribal colleges, and health programs in preparing competitive NARCH applications. This grant opportunity, classified under the R34 Planning Grant mechanism, focuses on enhancing research capacity, community engagement, and addressing health disparities within AI/AN populations, with a maximum funding limit of $225,000 in direct costs over a two-year period. Eligible applicants may submit one application per due date, and collaborative projects with non-AI/AN partners are permitted, provided that at least 75% of the funding is allocated to AI/AN entities. Interested parties can find more information and apply by July 8, 2026, by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-041.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Implementation Research on Non-Communicable Disease (NCD) Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments.
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) intends to publish a Funding Opportunity Announcement (FOA) for implementation research focused on non-communicable disease (NCD) risk factors among low- and middle-income countries (LMICs) and American Indian/Alaska Native (AI/AN) populations living in urban environments. The objective is to solicit applications that propose innovative strategies to reduce NCD risks, addressing environmental factors such as pollution and urban infrastructure that contribute to health disparities in city settings. This initiative is critical as chronic NCDs are a leading cause of morbidity and mortality globally, exacerbated by the COVID-19 pandemic, and aims to equip policymakers with evidence-based interventions. Interested applicants should note that applications will be accepted from U.S. and eligible LMIC institutions, with anticipated FOAs to be published in Fall 2022 and application due dates expected in Winter/Spring 2023. For further inquiries, contact Brad Newsome, PhD, at brad.newsome@nih.gov or call 301-480-8389.
    Notice of Intent to Publish a Funding Opportunity Announcement for Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for a single-source grant aimed at establishing the NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network. This initiative seeks to partner with private institutions of higher education to conduct large-scale, multi-site clinical trials, focusing on late-phase treatment trials and advanced imaging across various cancer types, while ensuring regulatory oversight in Canada. The funding, estimated at $3.8 million, is intended to support the NCTN's efforts to enhance clinical research for diverse patient populations, with the application due in late February 2025 and the award anticipated by March 1, 2026. Interested applicants should prepare their proposals in advance of the expected NOFO publication in Fall 2024.
    Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE)" aimed at fostering collaborations between institutions serving underserved populations and NCI-designated Cancer Centers. The initiative seeks to enhance cancer research capacity, promote workforce diversity, and implement community outreach initiatives to address cancer health disparities. This program is vital for developing comprehensive research projects that include administrative cores, research education, and outreach efforts, ultimately contributing to a stronger national cancer program. Eligible applicants can request funding of up to $2.2 million over five years, with the application submission period starting on December 15, 2023. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the NCI National Clinical Trials Network (NCTN) - Network Group Operations Centers, which will require a U10 clinical trial. This initiative aims to provide scientific leadership for the development and implementation of multi-disciplinary, multi-institutional clinical trials targeting various cancer types and populations, focusing on late-phase treatment trials and advanced imaging studies. The funding, estimated at $99.3 million, is intended to support the conduct of essential clinical research for adults, adolescents, and children with cancer, with the NOFO expected to be published in Fall 2024 and applications due by late February 2025. For further details, applicants should prepare their submissions in advance of the anticipated award date of March 1, 2026.
    Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities" (R01, Clinical Trial Required). This initiative aims to solicit applications for projects that identify and address barriers to cancer screening and preventive services, particularly in underserved populations, through multi-level interventions involving patients, clinicians, healthcare settings, and community partners. The focus is on developing evidence-based strategies to improve cancer outcomes for groups such as Black Americans, Hispanics, and Native Americans, emphasizing health equity and structured research methodologies. Interested applicants can find more details and submit proposals by January 7, 2027, with the first application due date being October 5, 2023. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov, and further information is available at NIH Grants.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the NCI National Clinical Trials Network, specifically targeting Network Lead Academic Participating Sites through a cooperative agreement. The primary objective is to provide scientific leadership in developing and conducting multi-center clinical trials for various cancer treatments, contributing to substantial patient accrual across the NCTN. This initiative is crucial for advancing clinical research and improving treatment options for diverse patient populations affected by cancer. The estimated total program funding is $35,100,000, with an award ceiling of $1,700,000 and approximately 35 awards expected. Interested applicants should prepare for the anticipated application due date in late February 2025, following the NOFO publication in Fall 2024.